Objectives: To investigate the association between the mode of birth and adverse neonatal outcomes of macrosomic (birthweight ≥4000g) and non-macrosomic (birthweight <4000g) live-born term singletons in vertex presentation (TSV) born to mothers with diabetes (preexisting and gestational diabetes mellitus (GDM)).
INTRODUCTION
Diabetes during pregnancy is associated with increased incidence of adverse baby outcomes. 1 Babies born to mothers with diabetes during pregnancy are at higher risk of perinatal mortality and morbidity including preterm birth, congenital abnormality, neonatal hypoglycaemia and macrosomia. 2 There is little consistency internationally regarding recommendations on the mode of birth for women with diabetes during pregnancy. Variations are seen in both national and professional society guidelines and recommendations. 2 The American College of Obstetricians and
Gynecologists guidelines recommend caesareansection (CS) for women with diabetes during pregnancy with an estimated birthweight >4500g. 3, 4 The National Institute for Health and Care Excellence (NICE) guideline in the United Kingdom recommends induction of labour or elective CS if indicated, between 37 +0 and 38 +6 weeks of gestation for women with preexisting diabetes. 5 For women with gestational diabetes (GDM), the NICE guideline recommends elective birth no later than 40 +6 weeks of gestation. 5 The Australasian Diabetes in Pregnancy Society (ADIPS) guidelines advise that for women with pre-existing diabetes, elective CS should be considered if estimated birthweight exceeds 4,250-4,500g. 6 For women with uncomplicated GDM, ADIPS guideline does not recommend birth before term unless there is an obstetric indication. 7 The rate of CS is high among women with diabetes during pregnancy in Australia 8 . The leading reasons for a planned CS (pre-labour CS) are for the prevention of stillbirth and the reduction of birth complications associated with macrosomia. 2, 9 Currently, there are no population-based studies in Australia that have evaluated the neonatal outcomes of babies born to mothers with diabetes according to the mode of birth.
Our study aimed to investigate the association between the mode of birth and adverse neonatal outcomes of macrosomic (birthweight ≥4000g) and non-macrosomic (birthweight <4000g) live-born term singletons in vertex presentation (TSV) born to mothers with diabetes during pregnancy. 
MATERIAL AND METHODS

Data source
A population-based retrospective cohort study was conducted using the New South Wales (NSW) Perinatal Data Collection (PDC). 10 The PDC is a population-based surveillance system. It includes all births occurring in NSW public and private hospitals as well as home births. Women giving birth to live-births and stillbirths of at least 20 weeks or at least 400g birthweight are included in the database. Around 32% of the Australian population lives in NSW, and more than 95 000 women give birth in this state annually.
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The NSW PDC is based on electronic forms that are completed at birth by the attendants.
Information on maternal demographics, maternal health, pregnancy, obstetric complications, labour and perinatal outcomes are included in the form. The forms are submitted to NSW
Ministry of Health where the information is validated and compiled into the state-wide PDC.
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Study population
The study includes all live-born TSV (n=48 882) born in NSW to mothers with diabetes during pregnancy between 1 st January 2002 and 31 st December 2012. Of these, 4501 (9.2%)
were born to mothers with pre-existing diabetes and 44 381 (90.8%) were born to mothers with GDM.
Of our study population, 276 (0.4%) TSV were excluded from the multivariate analysis due to admision to neonatal intensive care unit (NICU) or special care nursery (SCN) with one or more diagnosed birth defects, and 71 (0.1%) were excluded because of missing data (mode of birth, birthweight, and admission to NICU or SCN due to birth defect). A total of 4 458 liveborn TSV born to mothers with pre-existing diabetes and 44 148 born to mothers with GDM were included in the multivariate analysis.
Study factors and outcome measurements
Pre-existing diabetes includes Type I and Type II. GDM is defined as glucose intolerance that is diagnosed for the first time during pregnancy which may include hyperglycaemia induced by pregnancy or previously undiagnosed existing abnormalities of glucose tolerance. 
Statistical analysis
Maternal characteristics and baby outcomes were compared by mode of birth using Chisquare test. Trend analysis was used to compare the rate of pre-labour CS by year using Mantel-Haenszel test for trend analysis.
Multivariate logistic regression was used to investigate the likelihood of adverse neonatal outcomes by mode of birth. Two analyses were conducted; the first compared TSV born by pre-labour CS with TSV born by all other modes of birth combined as planned vaginal births.
The second compared TSV born by non-instrumental vaginal birth, TSV who were planned as vaginal births but for whom resorting to instrumental birth and intrapartum CS, and TSV born by pre-labour CS.
Adjusted odds ratio (AOR) and 95% confidence interval (CI) were presented. The adjustment was made for maternal age, maternal country of birth (Australian-born mothers, overseas-
Maternal characteristics and baby outcomes are presented in Tables 1 and 2 . Among mothers who went into labour, 38.8% of mothers with pre-existing diabetes and 31.5% of mothers with GDM gave birth by instrumental vaginal birth or intrapartum CS. The highest proportion of mothers aged <25 years were among mothers with pre-existing diabetes who gave birth by instrumental vaginal birth (16.9% p<0.001) ( Table 1 ). The proportion of primiparae mothers was higher among those who had instrumental vaginal birth (70.5% and 77.3% among mothers with pre-existing diabetes and mothers with GDM respectively) ( Tables 1 and 2 ). Figure 1 shows an increasing trend in pre-labour CS for both macrosomic and nonmacrosomic TSV. The largest increase was seen among macrosomic TSV (p=0.048).
Followed by non-macrosomic TSV born to mothers with pre-existing diabetes (p=0.032).
Among mothers with pre-existing diabetes in the planned vaginal birth group, the highest rate of instrumental vaginal birth was among mothers to non-macrosomic TSV who had induction of labour (13.2%)( Figure S1 ). Mothers with GDM who had induction of labour and gave birth to non-macrosomic TSV had the highest rate of instrumental vaginal birth (15.2%) ( Figure S2 ).
There were no significant changes in the rate of admission to NICU/SCN for TSV born to mothers with pre-existing diabetes and for macrosomic TSV born to mothers with GDM from 2002 to 2012. There was a significant increase in the rate of high-level resuscitation for nonmacrosomic TSV born to mothers with GDM between 2002 and 2012.
Pre-labour CS compared to planned vaginal birth
For TSV born to mothers with pre-existing diabetes by pre-labour CS, there was a significant increase in the odds of admission to NICU/SCN compared to TSV born by planned vaginal birth (AOR 2.3, 95% CI; 1.7 to 3.2 for macrosomic; AOR 1.6, 95% CI; 1.4 to 1.9 for nonmacrosomic TSV) ( Table 3) . 1.6 to 3.4 for intrapartum CS) ( Table 4) .
For macrosomic TSV, instrumental vaginal birth was associated with a significant increase in the odds of requiring high-level resuscitation (AOR 2.6, 95% CI; 1.2 to 5.7) and admission to NICU/SCN (AOR 2.1, 95% CI; 1.1 to 3.9) compared to non-instrumental vaginal birth (Table   4) .
TSV born to mothers with GDM
Among non-macrosomic TSV, compared with non-instrumental vaginal birth, all other modes of birth were associated with increased odds of admission to NICU/SCN (AOR 1.5, 95% CI; 1.4 to 1.6 for instrumental vaginal birth; AOR 1.9, 95% CI; 1.7-2.0 for intrapartum CS; AOR 1.6, 95% CI; 1.5 to 1.7 for pre-labour CS), and high-level resuscitation (AOR 2.5, 95% CI, 2.2-2.9 for instrumental vaginal birth; AOR 2.3, 95% CI; 2.1 to 2.7 for intrapartum CS; AOR 1.5, 95% CI; 1.3 to 1.7 for pre-labour CS) ( Table 4) .
Among macrosomic TSV born to GDM mothers, compared to non-instrumental vaginal birth, the rate of requiring high-levels of resuscitation was higher after instrumental vaginal birth (AOR 2.3, 95% CI; 1.7 to 3.1) and lower after pre-labour CS (AOR 0.7, 95% CI; 0.6 to 0.9)( Table 4 ). 
DISCUSSION
To our knowledge, this Australian study is the largest population-based investigation of neonatal outcomes related to mode of birth in live-born TSV born to mothers with diabetes during pregnancy. The study results showed that, among TSV born to mothers with diabetes during pregnancy, pre-labour CS was associated with a significant increase in the rate of admission to NICU/SCN compared to planned vaginal birth. Both instrumental vaginal birth and intrapartum CS were associated with increased odds of requiring high-levels of resuscitation compared to non-instrumental vaginal birth.
The use of a large validated population-based dataset with high accuracy 15 The limitation of the study is the lack of information on reasons for NICU/SCN admissions and maternal body mass index. To remove the confounding related to birth defects, we excluded TSV admitted to NICU/SCN because of birth defects from our multivariable logistic regression. However, we are unable to adjust for maternal body mass index, an independent risk factor for adverse pregnancy outcomes such as low Apgar score and a higher rate of admission to NICU. 17 We used stratification by estimated fetal macrosomia using birthweight to limit the impact of maternal body mass index on the mode of birth and neonatal outcomes.
There was no significant difference in the odds of 5-min Apgar score <7 between TSV born after pre-labour CS and those born after planned vaginal birth for mothers who had preexisting diabetes or GDM. found a significant reduction in the odds of 5-min Apgar score <7 among TSV born to mothers with diabetes during pregnancy who were born after pre-labour CS at 38 weeks gestation compared to those born after planned vaginal birth at 39 weeks gestation.
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TSV born to mothers with diabetes during pregnancy can be affected by a number of morbidities including respiratory distress syndrome, hypoglycaemia and hypocalcaemia that
can lead to an increase in the likelihood of admission to NICU/SCN 5 . In addition, CS is associated with increased odds of neonatal respiratory morbidity 19 . The NICE guideline recommended admission to NICU if babies who were born to mothers with diabetes had one of the following symptoms: hypoglycaemia, respiratory distress or jaundice, signs of cardiac decompensation, neonatal encephalopathy or polycythaemia, the need for tube feeding or who were born preterm. 5 Our study found that instrumental vaginal birth and intrapartum CS were associated with an increase in the odds of high-level resuscitation and admission to NICU/SCN compared to non-instrumental vaginal birth. One indication for instrumental vaginal birth and intrapartum CS is fetal compromise, 20 which is also an indication for neonatal resuscitation. 21 Thus, requiring high-level resuscitation might have been associated with fetal compromise, not the use of instrumental vaginal birth or intrapartum CS. However, instrumental vaginal birth alone is also considered a risk factor for requiring neonatal resuscitation. 21 Our study found that women with diabetes have a low rate of non-instrumental vaginal birth and high rate of giving birth by intrapartum CS and instrumental birth. This is consistent with previous studies. 18, 22 Among our population, of mothers who went into labour, 38.8% of those with pre-existing diabetes and 31.5% of those with GDM gave birth by instrumental vaginal birth or intrapartum CS compared with 29.4% of women in the NSW general population. 23 One in four mothers (25.9%) with planned vaginal birth gave birth to a macrosomic TSV by intrapartum CS, and one in five mothers (20.5%) with planned vaginal birth gave birth to a non-macrosomic TSV by instrumental vaginal birth. Given that both intrapartum CS and instrumental birth are associated with increased odds of adverse neonatal outcomes, the high proportion of resorting to instrumental vaginal birth for non-macrosomic TSV or intrapartum CS for macrosomic TSV should be considered when planning vaginal births.
Although pre-labour CS was associated with a reduction in some adverse neonatal outcomes, specifically requiring high-level resuscitation for macrosomic TSV, pre-labour CS is associated with adverse maternal outcomes. In the general population, CS is associated with immediate risk to the mother of infection, haemorrhage, anaesthetic risks and mortality. 24 It is also associated with an increased likelihood of repeat elective caesarean section in future pregnancies and increased risk of stillbirth and placenta praevia and accrete, uterine rupture, and peripartum hysterectomy. 24 The risk of adverse maternal outcomes following CS might
be escalated for women with diabetes during pregnancy since they are at higher risk of adverse maternal outcomes (such as infection and impaired wound healing) than women without diabetes.
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Conclusion
Of mothers with planned vaginal birth, one in four gave birth to a macrosomic TSV by intrapartum CS and one in five gave birth to a non-macrosomic TSV by instrumental vaginal birth. The potential risk of adverse neonatal outcomes associated with intrapartum CS and instrumental vaginal birth should be considered when planned for birth of women with diabetes. Close monitoring and readiness to intervene are needed when planned labour for TSV, particularly when the baby is macrosomic as CS is often required to expedite birth. live-born term singletons in vertex presentation (TSV) born to mothers with diabetes (preexisting and gestational diabetes mellitus (GDM)).
Design: A population-based retrospective cohort study.
Setting: New South Wales, Australia. 
What is known about this topic:
Diabetes during pregnancy is associated with adverse neonatal and long term baby outcomes.
There is no agreement in the national and international guidelines about the best mode of birth for women with diabetes during pregnancy.
What this study adds:
Diabetic women who gave birth to macrosomic TSV are likely to give birth by intrapartum CS and those who gave birth to non-macrosomic by instrumental birth. Intrapartum CS and instrumental vaginal birth are associated with increased likelihood of adverse neonatal outcomes.
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Information on maternal demographics, maternal health, pregnancy, obstetric complications, labour and perinatal outcomes are included in the form. The forms are submitted to NSW Ministry of Health where the information is validated and compiled into the state-wide PDC.
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Study population
There were 48 983 TSV born during the study period of these 101 stillbirth (18 (0.4%) born to mothers with pre-existing diabetes and 83 (0.2%) born to mothers with GDM). Due to our inability to identify times of stillbirth (antepartum or intrapartum), these stillbirths were excluded from the study. The study includes all live-born TSV (n=48 882) born in NSW to mothers with diabetes during pregnancy between 1 st January 2002 and 31 st December 2012.
Of these, 4501 (9.2%) were born to mothers with pre-existing diabetes and 44 381 (90.8%)
were born to mothers with GDM.
Of our study population, 276 (0.4%) TSV were excluded from the multivariate logistic regression due to admision to neonatal intensive care unit (NICU) or special care nursery (SCN) with one or more diagnosed birth defects, and 71 (0.1%) were excluded because of missing data (mode of birth, birthweight, and admission to NICU or SCN due to birth defect).
A total of 4 458 live-born TSV born to mothers with pre-existing diabetes and 44 148 born to mothers with GDM were included in the multivariate logistic regression. 
Study factors and outcome measurements
Statistical analysis
This first analysis was performed to inform the decision of performing pre-labour caesarean section or proceed to planned vaginal birth. The second compared TSV born by noninstrumental vaginal birth, TSV who were planned as vaginal births but for whom resorting to instrumental birth and intrapartum CS, and TSV born by pre-labour CS. The second analysis was performed to help inform the decision in the situation were vaginal birth is planned.
Adjusted odds ratio (AOR) and 95% confidence interval (CI) were presented. Tables 1 and 2 . Among mothers who went into labour, 38.8% of mothers with pre-existing diabetes and 31.5% of mothers with GDM gave birth by instrumental vaginal birth or intrapartum CS. The highest proportion of mothers aged <25 years were among mothers with pre-existing diabetes who gave birth by instrumental vaginal birth (16.9% p<0.001) ( Table 1 ). The proportion of primiparae mothers was higher among those who had instrumental vaginal birth (70.5% and 77.3% among mothers with pre-existing diabetes and mothers with GDM respectively) ( Tables 1 and 2 ).
RESULTS
Maternal characteristics and baby outcomes are presented in
There were 17 neonatal deaths of these two (0.4 per 1000 live-born TSV) born to women with pre-existing diabetes and 15 (0.3 per 1000 live-born TSV) born to women with GDM. Figure 1 shows an increasing trend in pre-labour CS for both macrosomic and nonmacrosomic TSV. The largest increase was seen among macrosomic TSV (p=0.048).
Pre-labour CS compared to planned vaginal birth
For TSV born to mothers with pre-existing diabetes by pre-labour CS, there was a significant increase in the odds of admission to NICU/SCN compared to TSV born by planned vaginal birth (AOR 2.3, 95% CI; (1.7 to 3.2) for macrosomic; AOR 1.6, 95% CI; (1.4 to 1.9) for nonmacrosomic TSV) ( Table 3) . for intrapartum CS) ( Table 4) .
For macrosomic TSV, instrumental vaginal birth was associated with a significant increase in the odds of requiring resuscitation (AOR 2.6, 95% CI; (1.2 to 5.7)) and admission to NICU/SCN (AOR 2.1, 95% CI; (1.1 to 3.9)) compared to non-instrumental vaginal birth (Table 4) .
TSV born to mothers with GDM
Among non-macrosomic TSV, compared with non-instrumental vaginal birth, all other modes of birth were associated with increased odds of admission to NICU/SCN (AOR 1.5, 95% CI; (1.4 to 1.6) for instrumental vaginal birth; AOR 1.9, 95% CI; (1.7-2.0) for intrapartum CS; AOR 1.6, 95% CI; (1.5 to 1.7) for pre-labour CS), and need for resuscitation (AOR 2.5, 95% CI, (2.2-2.9) for instrumental vaginal birth; AOR 2.3, 95% CI; (2.1 to 2.7)
for intrapartum CS; AOR 1.5, 95% CI; (1.3 to 1.7) for pre-labour CS) ( Table 4) .
Among macrosomic TSV born to GDM mothers, compared to non-instrumental vaginal birth, the rate of requiring resuscitation was higher after instrumental vaginal birth (AOR 2.3, 95% CI; (1.7 to 3.1)) and lower after pre-labour CS (AOR 0.7, 95% CI; (0.6 to 0.9))( Table 4) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The limitation of the study is the lack of information on reasons for NICU/SCN admissions as macrosomic TSV are routinely admitted to NICU/SCN for expected hypoglycaemia without clinical necessity which increases the rate of admission to NICU/SCN. Some services do have a routine policy of admitting babies born to mothers with diabetes to a NICU/SCN hence the numbers could be higher. Another limitation is the lack of information on maternal body mass index and on umbilical artery pH and lactate levels. To remove the confounding related to birth defects, we excluded TSV admitted to NICU/SCN because of birth defects from our multivariable logistic regression. However, we are unable to adjust for maternal body mass index, an independent risk factor for adverse pregnancy outcomes such as low Apgar score and a higher rate of admission to NICU. 17 We used stratification by estimated fetal macrosomia using birthweight to limit the impact of maternal body mass index on the mode of birth and neonatal outcomes. We are also unable to adjust for shoulder dystocia as it was not captured in NSW PDC. We also lack information on second stage CS which did not allow us to compare between intrapartum CS and instrumental vaginal birth.
There was no significant difference in the odds of 5-min Apgar score <7 between TSV born after pre-labour CS and those born after planned vaginal birth for mothers who had pre- . The NICE guideline recommended admission to NICU if babies who were born to mothers with diabetes had one of the following symptoms: hypoglycaemia, respiratory distress or jaundice, signs of cardiac decompensation, neonatal encephalopathy or polycythaemia, the need for tube feeding or who were born preterm. 5 Our study found that instrumental vaginal birth and intrapartum CS were associated with an increase in the odds of the need for resuscitation and admission to NICU/SCN compared to non-instrumental vaginal birth. One indication for instrumental vaginal birth and intrapartum CS is fetal compromise, 20 which is also an indication for neonatal resuscitation. 21 Thus, requiring resuscitation might have been associated with fetal compromise, not the use of instrumental vaginal birth or intrapartum CS. However, instrumental vaginal birth alone is also considered a risk factor for requiring neonatal resuscitation. 21 Our study found that women with diabetes have a low rate of non-instrumental vaginal birth and high rate of giving birth by intrapartum CS and instrumental birth. This is consistent with previous studies. 18, 22 Among our population, of mothers who went into labour, 38.8% of those with pre-existing diabetes and 31.5% of those with GDM gave birth by instrumental vaginal birth or intrapartum CS compared with 29.4% of women in the NSW general population. 23 One in four mothers (25.9%) with planned vaginal birth gave birth to a macrosomic TSV by intrapartum CS, and one in five mothers (20.5%) with planned vaginal birth gave birth to a non-macrosomic TSV by instrumental vaginal birth. Given that both intrapartum CS and instrumental birth are associated with increased odds of adverse neonatal outcomes, the high proportion of resorting to instrumental vaginal birth for non-macrosomic TSV or intrapartum CS for macrosomic TSV should be considered when planning vaginal births. Although pre-labour CS was associated with a reduction in some adverse neonatal outcomes, specifically requiring resuscitation for macrosomic TSV, pre-labour CS is associated with adverse maternal outcomes. In the general population, CS is associated with immediate risk to the mother of infection, haemorrhage, anaesthetic risks and mortality. 24 It is also associated with an increased likelihood of repeat elective caesarean section in future pregnancies and increased risk of stillbirth and placenta praevia and accrete, uterine rupture, and peripartum hysterectomy. 24 The risk of adverse maternal outcomes following CS might be escalated for women with diabetes during pregnancy since they are at higher risk of adverse maternal outcomes (such as infection and impaired wound healing) than women without diabetes.
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Conclusion
Of mothers with planned vaginal birth, one in four gave birth to a macrosomic TSV by intrapartum CS and one in five gave birth to a non-macrosomic TSV by instrumental vaginal birth. The potential risk of adverse neonatal outcomes associated with intrapartum CS and instrumental vaginal birth should be considered when planned for birth of women with diabetes. Close monitoring and readiness to intervene are needed when planned labour for TSV, particularly when the baby is macrosomic as CS is often required to expedite birth. Figure S1 : Onset of labour and mode of birth for mothers with pre-existing diabetes who gave birth to macrosomic and non-macrosomic TSV 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
